Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

Orhan Agcaoglu; Atakan Sezer; Ozer Makay; Murat Faik Erdogan; Fahri Bayram; Sibel Guldiken; Marco Raffaelli; Yusuf Alper Sonmez; Yong-Sang Lee; Kyriakos Vamvakidis; Radu Mihai; Quan-Yang Duh; Baris Akinci; Faruk Alagol; Martin Almquist; Marcin Barczynski; Taner Bayraktaroglu; Eren Berber; Yusuf Bukey; Guldeniz Karadeniz Cakmak; Nuh Zafer Canturk; Zeynep Canturk; Mehmet Celik; Ozlem Celik; Banu Ozturk Ceyhan; Sergii Cherenko; Thomas Clerici; David Scott Coombes; Orhan Demircan; Oguzhan Deyneli; Gianlorenzo Dionigi; Ali Ugur Emre; Yesim Erbil; Ali Ilker Filiz; Hulya Ilıksu Gozu; Sibel Ozkan Gurdal; Gunay Gurleyik; Mehmet Haciyanli; Abut Kebudi; Seokmo Kim; Giannis Koutelidakis; Bekir Kuru; Meral Mert; Guzide Gonca Oruk; Serdar Ozbas; Fausto Palazzo; Rumen Pandev; Phillip Riss; Tevfik Sabuncu; Ibrahim Sahin; Gurhan Sakman; Fusun Saygili; Yasemin Giles Senyurek; Ilya Sleptsov; Sam Van Slycke; Serkan Teksoz; Tarik Terzioglu; Serdar Tezelman; Fatih Tunca; Mustafa Umit Ugurlu; Mehmet Uludag; Jesus Villar-Del-Moral; Menno Vriens; Dilek Yazici

doi:10.1007/s13304-021-00979-8

Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

Orhan Agcaoglu, Atakan Sezer, Ozer Makay, Murat Faik Erdogan, Fahri Bayram, Sibel Guldiken, Marco Raffaelli, Yusuf Alper Sonmez, Yong-Sang Lee, Kyriakos Vamvakidis, Radu Mihai, Quan-Yang Duh, Baris Akinci, Faruk Alagol, Martin Almquist, Marcin Barczynski, Taner Bayraktaroglu, Eren Berber, Yusuf Bukey, Guldeniz Karadeniz CakmakNuh Zafer Canturk, Zeynep Canturk, Mehmet Celik, Ozlem Celik, Banu Ozturk Ceyhan, Sergii Cherenko, Thomas Clerici, David Scott Coombes, Orhan Demircan, Oguzhan Deyneli, Gianlorenzo Dionigi, Ali Ugur Emre, Yesim Erbil, Ali Ilker Filiz, Hulya Ilıksu Gozu, Sibel Ozkan Gurdal, Gunay Gurleyik, Mehmet Haciyanli, Abut Kebudi, Seokmo Kim, Giannis Koutelidakis, Bekir Kuru, Meral Mert, Guzide Gonca Oruk, Serdar Ozbas, Fausto Palazzo, Rumen Pandev, Phillip Riss, Tevfik Sabuncu, Ibrahim Sahin, Gurhan Sakman, Fusun Saygili, Yasemin Giles Senyurek, Ilya Sleptsov, Sam Van Slycke, Serkan Teksoz, Tarik Terzioglu, Serdar Tezelman, Fatih Tunca, Mustafa Umit Ugurlu, Mehmet Uludag, Jesus Villar-Del-Moral, Menno Vriens, Dilek Yazici

Research output: Contribution to journal › Article

Abstract

PURPOSE: The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic.METHODS: We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire.RESULTS: Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole±beta-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma.CONCLUSION: This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible.

Original language	English
Pages (from-to)	1-11
Number of pages	11
Journal	Updates in Surgery
DOIs	https://doi.org/10.1007/s13304-021-00979-8
Publication status	Published - 2021

Keywords

Consensus
Endocrine disease
Expert opinion
Pandemic
Qualtrics
Survey

Access to Document

10.1007/s13304-021-00979-8

Cite this

Agcaoglu, O., Sezer, A., Makay, O., Erdogan, M. F., Bayram, F., Guldiken, S., Raffaelli, M., Sonmez, Y. A., Lee, Y.-S., Vamvakidis, K., Mihai, R., Duh, Q.-Y., Akinci, B., Alagol, F., Almquist, M., Barczynski, M., Bayraktaroglu, T., Berber, E., Bukey, Y., ... Yazici, D. (2021). Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options. Updates in Surgery, 1-11. https://doi.org/10.1007/s13304-021-00979-8

@article{d0d0a3d602654ea5a1112f1ca57f57ad,

title = "Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options",

abstract = "PURPOSE: The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic.METHODS: We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire.RESULTS: Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole±beta-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma.CONCLUSION: This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible.",

keywords = "Consensus, Endocrine disease, Expert opinion, Pandemic, Qualtrics, Survey, Consensus, Endocrine disease, Expert opinion, Pandemic, Qualtrics, Survey",

author = "Orhan Agcaoglu and Atakan Sezer and Ozer Makay and Erdogan, {Murat Faik} and Fahri Bayram and Sibel Guldiken and Marco Raffaelli and Sonmez, {Yusuf Alper} and Yong-Sang Lee and Kyriakos Vamvakidis and Radu Mihai and Quan-Yang Duh and Baris Akinci and Faruk Alagol and Martin Almquist and Marcin Barczynski and Taner Bayraktaroglu and Eren Berber and Yusuf Bukey and Cakmak, {Guldeniz Karadeniz} and Canturk, {Nuh Zafer} and Zeynep Canturk and Mehmet Celik and Ozlem Celik and Ceyhan, {Banu Ozturk} and Sergii Cherenko and Thomas Clerici and Coombes, {David Scott} and Orhan Demircan and Oguzhan Deyneli and Gianlorenzo Dionigi and Emre, {Ali Ugur} and Yesim Erbil and Filiz, {Ali Ilker} and Gozu, {Hulya Ilıksu} and Gurdal, {Sibel Ozkan} and Gunay Gurleyik and Mehmet Haciyanli and Abut Kebudi and Seokmo Kim and Giannis Koutelidakis and Bekir Kuru and Meral Mert and Oruk, {Guzide Gonca} and Serdar Ozbas and Fausto Palazzo and Rumen Pandev and Phillip Riss and Tevfik Sabuncu and Ibrahim Sahin and Gurhan Sakman and Fusun Saygili and Senyurek, {Yasemin Giles} and Ilya Sleptsov and {Van Slycke}, Sam and Serkan Teksoz and Tarik Terzioglu and Serdar Tezelman and Fatih Tunca and Ugurlu, {Mustafa Umit} and Mehmet Uludag and Jesus Villar-Del-Moral and Menno Vriens and Dilek Yazici",

year = "2021",

doi = "10.1007/s13304-021-00979-8",

language = "English",

pages = "1--11",

journal = "Updates in Surgery",

issn = "2038-131X",

publisher = "Milano : Springer-Verlag Italia",

}

Agcaoglu, O, Sezer, A, Makay, O, Erdogan, MF, Bayram, F, Guldiken, S, Raffaelli, M, Sonmez, YA, Lee, Y-S, Vamvakidis, K, Mihai, R, Duh, Q-Y, Akinci, B, Alagol, F, Almquist, M, Barczynski, M, Bayraktaroglu, T, Berber, E, Bukey, Y, Cakmak, GK, Canturk, NZ, Canturk, Z, Celik, M, Celik, O, Ceyhan, BO, Cherenko, S, Clerici, T, Coombes, DS, Demircan, O, Deyneli, O, Dionigi, G, Emre, AU, Erbil, Y, Filiz, AI, Gozu, HI, Gurdal, SO, Gurleyik, G, Haciyanli, M, Kebudi, A, Kim, S, Koutelidakis, G, Kuru, B, Mert, M, Oruk, GG, Ozbas, S, Palazzo, F, Pandev, R, Riss, P, Sabuncu, T, Sahin, I, Sakman, G, Saygili, F, Senyurek, YG, Sleptsov, I, Van Slycke, S, Teksoz, S, Terzioglu, T, Tezelman, S, Tunca, F, Ugurlu, MU, Uludag, M, Villar-Del-Moral, J, Vriens, M & Yazici, D 2021, 'Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options', Updates in Surgery, pp. 1-11. https://doi.org/10.1007/s13304-021-00979-8

TY - JOUR

T1 - Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

AU - Agcaoglu, Orhan

AU - Sezer, Atakan

AU - Makay, Ozer

AU - Erdogan, Murat Faik

AU - Bayram, Fahri

AU - Guldiken, Sibel

AU - Raffaelli, Marco

AU - Sonmez, Yusuf Alper

AU - Lee, Yong-Sang

AU - Vamvakidis, Kyriakos

AU - Mihai, Radu

AU - Duh, Quan-Yang

AU - Akinci, Baris

AU - Alagol, Faruk

AU - Almquist, Martin

AU - Barczynski, Marcin

AU - Bayraktaroglu, Taner

AU - Berber, Eren

AU - Bukey, Yusuf

AU - Cakmak, Guldeniz Karadeniz

AU - Canturk, Nuh Zafer

AU - Canturk, Zeynep

AU - Celik, Mehmet

AU - Celik, Ozlem

AU - Ceyhan, Banu Ozturk

AU - Cherenko, Sergii

AU - Clerici, Thomas

AU - Coombes, David Scott

AU - Demircan, Orhan

AU - Deyneli, Oguzhan

AU - Dionigi, Gianlorenzo

AU - Emre, Ali Ugur

AU - Erbil, Yesim

AU - Filiz, Ali Ilker

AU - Gozu, Hulya Ilıksu

AU - Gurdal, Sibel Ozkan

AU - Gurleyik, Gunay

AU - Haciyanli, Mehmet

AU - Kebudi, Abut

AU - Kim, Seokmo

AU - Koutelidakis, Giannis

AU - Kuru, Bekir

AU - Mert, Meral

AU - Oruk, Guzide Gonca

AU - Ozbas, Serdar

AU - Palazzo, Fausto

AU - Pandev, Rumen

AU - Riss, Phillip

AU - Sabuncu, Tevfik

AU - Sahin, Ibrahim

AU - Sakman, Gurhan

AU - Saygili, Fusun

AU - Senyurek, Yasemin Giles

AU - Sleptsov, Ilya

AU - Van Slycke, Sam

AU - Teksoz, Serkan

AU - Terzioglu, Tarik

AU - Tezelman, Serdar

AU - Tunca, Fatih

AU - Ugurlu, Mustafa Umit

AU - Uludag, Mehmet

AU - Villar-Del-Moral, Jesus

AU - Vriens, Menno

AU - Yazici, Dilek

PY - 2021

Y1 - 2021

N2 - PURPOSE: The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic.METHODS: We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire.RESULTS: Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole±beta-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma.CONCLUSION: This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible.

AB - PURPOSE: The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic.METHODS: We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire.RESULTS: Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole±beta-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma.CONCLUSION: This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible.

KW - Consensus

KW - Endocrine disease

KW - Expert opinion

KW - Pandemic

KW - Qualtrics

KW - Survey

KW - Consensus

KW - Endocrine disease

KW - Expert opinion

KW - Pandemic

KW - Qualtrics

KW - Survey

UR - http://hdl.handle.net/10807/176734

U2 - 10.1007/s13304-021-00979-8

DO - 10.1007/s13304-021-00979-8

M3 - Article

SN - 2038-131X

SP - 1

EP - 11

JO - Updates in Surgery

JF - Updates in Surgery

ER -

Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this